Methods for Estimating VE Using Routine School Testing Data with Differential Testing Behavior

Paige Harton Co-Author
Emory University
 
Allison Chamberlain Co-Author
Emory University, Rollins School of Public Health
 
Elizabeth Rogawski-McQuade Co-Author
Emory University
 
Natalie Dean Co-Author
Emory University
 
Amy Moore First Author
 
Amy Moore Presenting Author
 
Tuesday, Aug 5: 9:30 AM - 9:35 AM
2362 
Contributed Speed 
Music City Center 
During the COVID-19 pandemic, many school systems implemented opt-in regular testing for students to track the spread of disease and detect cases early. Beyond the primary use of these testing programs as surveillance, the observational data collected from these programs can be leveraged to measure vaccine effectiveness (VE) among school-aged children. The data from these sources offers complicated challenges to the standard assumptions of vaccine effectiveness methodology, specifically when there is evidence of differential testing behavior between the vaccinated and unvaccinated groups. To combat this issue, we explore approaches to characterize the differences in testing behavior to improve the implementation of standard VE methodology. We apply 3 methods for measuring VE to the observational data: a target trial emulation approach with matching of participants across vaccination groups, a time-varying effect model of vaccination, and a test-negative design. For these methods we compare the losses to sample size due to study design, discuss approaches to adjust for differential testing behavior, and consider additional sources of bias due to unmet assumptions.

Keywords

Vaccine Effectiveness

Target Trial Emulation

Test-negative Design

Time-varying Effect

COVID-19

Observational Study 

Main Sponsor

ENAR